Cancer Drug, Nilotinib, May Slow Progression of Parkinson’s
- Hamilton, J. Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests. Published March 15, 2017. http://www.npr.org/sections/health-shots/2017/03/15/520170960/cancer-drug-that-might-slow-parkinson-s-alzheimer-s-headed-for-bigger-tests. Accessed online October 19, 2017.
- Kegel, M. Cancer Drug Raises Dopamine Levels, Eases Parkinson’s Symptoms in Early Study in Patients. Published July 18, 2016. https://parkinsonsnewstoday.com/2016/07/18/parkinsons-patients-seem-to-benefit-from-cancer-drug-nilotinib/. Accessed online October 19, 2017.
- The Science of Parkinson’s disease. Nilotinib: The other phase II trial. Published July 31, 2017. https://scienceofparkinsons.com/tag/nilotinib/. Accessed online October 19, 2017.